C. Leschke et al., SYNTHESIS AND HISTAMINE H-1 RECEPTOR AGONIST ACTIVITY OF A SERIES OF 2-PHENYLHISTAMINES, 2-HETEROARYLHISTAMINES, AND ANALOGS, Journal of medicinal chemistry, 38(8), 1995, pp. 1287-1294
New histamine derivatives characterized by a (substituted) aryl, heter
oaryl, benzyl, or heteroarylmethyl substituent in the C2 position of t
he imidazole ring have been prepared from appropriate imidates or amid
ines, respectively, and 2-oxo-4-phthalimido-1-butyl acetate (1). The c
ompounds were screened as potential H-1 receptor agonists on the isola
ted guinea pig ileum. The 3-halogenated 2-phenylhistamines (halogen =
Br (35) and I (36)) were equipotent with histamine, while 2-(3-(triflu
oromethyl)phenyl)histamine trifluoromethyl)phenyl)1H-imidazol-4-yl]eth
anamine (39)) was significantly more potent than histamine (39: pD(2)
= 6.81, relative activity = 128%). The 2-substituted histamine analogu
es were partial H-1 receptor agonists on the endothelium-denuded isola
ted guinea pig aorta with pEC(50) values generally smaller than observ
ed on the guinea pig ileum, but the rank order of potency was found to
be similar. The contractile effects on guinea pig ileum and aorta, re
spectively, could be blocked concentration-dependently by the H-1 rece
ptor antagonist mepyramine, yielding Kg values for mepyramine in the n
anomolar range. In vitro compounds 35 and 39 bound to [H-3]mepyramine-
labeled guinea pig cerebellar membranes with a pK(i) of 6.1 and 5.9, r
espectively. However, upon iv administration, 35 (3-100 mg/kg) and 39
(3-300 mg/kg) failed to inhibit the binding of [H-3]mepyramine to mous
e cerebral cortex in vivo, thereby indicating that these histamine der
ivatives are not able to penetrate the blood-brain barrier. In functio
nal in vitro studies on histamine H-2, H-3, and other neurotransmitter
receptors the selectivity of 39 was found to be 2138 (H-1:H-2), > 64
(H-1:H-3), 1000 (H-1:M(3)), 105 (H-1:alpha(1)), 708 (H-1:beta(1)), and
71 (H-1:5HT(2A)). Thus compound 39 is the most potent and selective H
-1 receptor agonist reported so far. These results make meta- substitu
ted 2-phenylhistamines, especially 2-(3-(trifluoromethyl)phenyl)- and
2-(3-bromophenyl)histamine (39 and 35, respectively) valuable experime
ntal tools for the selective stimulation of histamine H-1 receptors an
d the study of H-1 receptor-mediated functions.